NIH-funded research P01 program project

Understanding how immune cells affect red blood cell production in sickle cell disease

Official title: Erythroblastic Island Macrophages in SCD Disordered Erythropoiesis.

Funded at New York Blood Center · NIH-11015293 · Data updated 2026-11-12

This research explores how special immune cells called macrophages in the bone marrow might be causing problems with red blood cell production in people with sickle cell disease.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionNew York Blood Center
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 20, 2020
Project endJune 30, 2030
Funding year2025
Award (this year)$640,500
NIH project number2P01HL149626-06
Project IDNIH-11015293 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research is for patients with sickle cell disease who may benefit from future therapies that improve red blood cell production.

Less likely to help

Patients without sickle cell disease or related blood disorders would not directly benefit from this specific research.

What this research studies

Our bodies rely on special cells in the bone marrow, called erythroblastic island macrophages, to help make healthy red blood cells. In sickle cell disease, these macrophages may not work correctly, leading to issues with red blood cell formation and anemia. This project aims to understand how these macrophages become dysfunctional and how their communication with developing red blood cells is disrupted. We are looking at specific signals and pathways within these cells to find ways to restore their normal function and improve red blood cell production.

Why it matters

Potential benefit: If successful, this work could lead to new treatments that help the body produce more healthy red blood cells, potentially reducing anemia and other complications for individuals with sickle cell disease.

How similar studies have gone: While the role of these macrophages in red blood cell production is known, this specific approach to understanding their dysfunction in sickle cell disease is exploring new mechanisms.

Where this research is happening

  • New York Blood Center
    New York, United States
    Active

Researchers

  • Principal investigator: An, Xiuli — New York Blood Center
  • Study coordinator: An, Xiuli

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.